Literature DB >> 11778694

Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo.

H Moro1, K Iwai, N Mori, M Watanabe, M Fukushi, M Oie, M Arai, Y Tanaka, T Miyawaki, F Gejyo, M Arakawa, M Fujii.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is an etiologic agent of adult T-cell leukemia. HTLV-1 is exclusively detected in CD45RO+ T-cells in infected individuals, but CD45RO is weakly expressed in HTLV-1-transformed T-cell lines in vitro. The aim of this study was to investigate the role of CD45RO in the persistent HTLV-1 infection in vivo. Flow cytometry showed that only two out of eight interleukin(IL)-2-independent HTLV-1-transformed T-cell lines expressed CD45RO, whereas all five IL-2-dependent ones expressed CD45RO, and the level of expression was higher in IL-2-dependent than in IL-2-independent cells. The high CD45RO expression in IL-2-dependent cell lines was not due to IL-2, since IL-2 had little effect on the expression of CD45RO in T-cell lines. Using western blotting, we showed that IL-2-dependent HTLV-1-transformed T-cell lines expressed a lower level of expression of the viral transcriptional regulatory protein Tax than IL-2-independent ones, and that the level of expression correlated inversely with that of CD45RO. However, the expression of Tax in one HTLV-1-negative T-cell line little affected the expression of CD45RO, suggesting that Tax at least alone does not suppress the expression of CD45RO in HTLV-1-infected T-cell lines, and that other viral or cellular factor(s) are probably involved in such suppression. Our results suggest that CD45RO+ Tax-low IL-2-dependent T-cell lines in vitro correspond to the persistent HTLV-1-infected cells in vivo, and HTLV-1-infected cells in vivo are immortalized in IL-2-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778694     DOI: 10.1023/a:1012565105098

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  25 in total

Review 1.  CD45 and Src-family kinases: and now for something completely different.

Authors:  J D Ashwell; U D'Oro
Journal:  Immunol Today       Date:  1999-09

2.  Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.

Authors:  H Yssel; R de Waal Malefyt; M D Duc Dodon; D Blanchard; L Gazzolo; J E de Vries; H Spits
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

3.  Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I.

Authors:  A Inatsuki; M Yasukawa; Y Kobayashi
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

4.  IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II.

Authors:  T Yoshida; E Miyagawa; K Yamaguchi; S Kobayashi; Y Takahashi; A Yamashita; H Miura; Y Itoyama; N Yamamoto
Journal:  Int J Cancer       Date:  2001-01-01       Impact factor: 7.396

5.  Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).

Authors:  Y Tanaka; M Yasumoto; H Nyunoya; T Ogura; M Kikuchi; K Shimotohno; H Shiraki; N Kuroda; H Shida; H Tozawa
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

6.  Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.

Authors:  Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

7.  Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.

Authors:  K Sugamura; M Fujii; M Kannagi; M Sakitani; M Takeuchi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

8.  Human T-cell leukemia virus type 1 tax protein abrogates interleukin-2 dependence in a mouse T-cell line.

Authors:  Y Iwanaga; T Tsukahara; T Ohashi; Y Tanaka; M Arai; M Nakamura; K Ohtani; Y Koya; M Kannagi; N Yamamoto; M Fujii
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  3 in total

1.  Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Authors:  Andrea K Kress; Grit Schneider; Klemens Pichler; Martina Kalmer; Bernhard Fleckenstein; Ralph Grassmann
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

2.  Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes.

Authors:  Amrithraj Nair; Bindhu Michael; Hajime Hiraragi; Soledad Fernandez; Gerold Feuer; Kathleen Boris-Lawrie; Michael Lairmore
Journal:  AIDS Res Hum Retroviruses       Date:  2005-04       Impact factor: 2.205

Review 3.  Cell surface markers in HTLV-1 pathogenesis.

Authors:  Andrea K Kress; Ralph Grassmann; Bernhard Fleckenstein
Journal:  Viruses       Date:  2011-08-16       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.